FNCH

Finch Therapeutics Group, Inc. Common Stock
FNCH

Overview Fund Activity
Delisted

FNCH was delisted on the 24th of May, 2024.

Back to rankings

53 hedge funds and large institutions have $53.1M invested in Finch Therapeutics Group, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 2 closing their positions.

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
8
Reduced
20
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$1.66M
2
Qube Research & Technologies (QRT)
2
Qube Research & Technologies (QRT)
United Kingdom
$189K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$806K
4
BlackRock
4
BlackRock
New York
$2.04M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$226K

Top Sellers

1
MP
1
MSD Partners
New York
$1.96M
2
LSCM
2
Light Street Capital Management
California
$3.36M
3
E
3
Ergoteles
New York
$96K
4
Millennium Management
4
Millennium Management
New York
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$300K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
$2K -$9.46K -52 -83%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$2K -$4.88K -39 -71%
Millennium Management
53
Millennium Management
New York
– -$126K -421 Closed
Lazard Asset Management
54
Lazard Asset Management
New York
– -$1K -5 Closed
1 2
3